The findings were presented today at the FAST (Foundation for Angelman Syndrome Therapeutics) Summit; the presentation is available here. Angelman syndrome is caused by a loss of function in the UBE3A gene. Ionis’ Forward-looking StatementsThis press release includes forward-looking statements regarding Ionis’ business and the therapeutic and commercial potential of ION582, Ionis’ technologies, and other products in development. Ionis’ forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis’ forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis.

Source: The Bubble November 12, 2023 05:55 UTC